share_log

B of A Securities Downgrades Cardlytics to Underperform, Lowers Price Target to $3.5

B of A Securities Downgrades Cardlytics to Underperform, Lowers Price Target to $3.5

美國銀行證券將cardlytics股票評級下調爲低性能,將價格目標下調至3.5美元。
Benzinga ·  08/15 18:45  · 評級/大行評級

B of A Securities analyst Omar Dessouky downgrades Cardlytics (NASDAQ:CDLX) from Neutral to Underperform and lowers the price target from $4 to $3.5.

B的A證券分析師Omar Dessouky將Cardlytics(納斯達克:cardlytics)的評級從中立下調爲跑輸市場,並將價格目標從4美元下調至3.5美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論